It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Observation:
The anticonvulsant hypersensitivity syndrome is rare complication that occurs with the use of antiepileptic medications. All of the aromatic anticonvulsant drugs are metabolised by the cytochrome P-450 enzyme to a common arene oxide metabolite that is normally detoxified by epoxide hydrolase. A genetically determined inability to detoxify the toxic metabolites due to a defect in the enzyme epoxide hydrolase has been observed in patients with this hypersensitivity syndrome. We present a patient with severe phenytoin-induced hypersensitivity syndrome associated with glutathione S-transferase, N-acetyltransferase, and cytochrome P450 polymorphisms.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer